Memantine as an Augmenting Agent for Severe Pediatric OCD
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Memantine add-on to fluvoxamine significantly improved short-term outcomes in patients with moderate to severe OCD”
From The neurobiological link between OCD and ADHD (2014) · cites this paper as Hezel et al. 2009
Citations
Cites
Cortico-striatal synaptic defects and OCD-like behaviours in Sapap3-mutant mice
Welch, J. M., Lu, J., Rodriguiz, R. M., Trotta, N. C., Peca, J., Ding, J.-D., Feliciano, C., Chen, M., Adams, J. P., Luo, J., et al. (2007) · Nature · doi:10.1038/nature06104 · Cited by 852
Riluzole augmentation in treatment-resistant obsessive-compulsive disorder: An open-label trial
Coric, V., Taskiran, S., Pittenger, C., Wasylink, S., Mathalon, D. H., Valentine, G., Saksa, J., Wu, Y.-T., Gueorguieva, R., Sanacora, G., et al. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.04.043 · Cited by 314 · cited 1×
“Of note, riluzole (6), another glutamatergic medication, was reportedly effective in open trials in child (7) and adult (8) OCD samples.”
BackgroundPittenger, C., Krystal, J. H., & Coric, V. (2006) · NeuroRX · doi:10.1016/j.nurx.2005.12.006 · Cited by 222
Grant, P., Lougee, L., Hirschtritt, M., & Swedo, S. E. (2007) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2007.0021 · Cited by 197
Memantine for Treatment-Resistant OCD
Poyurovsky, M., Weizman, R., Weizman, A., & Koran, L. M. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.11.2191-a · Cited by 101
Memantine augmentation for refractory obsessive–compulsive disorder
Pasquini, M., & Biondi, M. (2006) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2006.04.013 · Cited by 100
Egashira, N., Okuno, R., Harada, S., Matsushita, M., Mishima, K., Iwasaki, K., Nishimura, R., Oishi, R., & Fujiwara, M. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.01.035 · Cited by 94
Research works printed but not linked: 1
- Rasmussen SA, 1990, J Clin Psychiatry, 51, 10
Cited by
Pittenger, C., Bloch, M. H., & Williams, K. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.09.006 · Cited by 426
The prevalence of mental disorders in older people in Western countries – a meta-analysis
Volkert, J., Schulz, H., Härter, M., Wlodarczyk, O., & Andreas, S. (2013) · Ageing Research Reviews · doi:10.1016/j.arr.2012.09.004 · Cited by 390
Sani, G., Serra, G., Kotzalidis, G. D., Romano, S., Tamorri, S. M., Manfredi, G., Caloro, M., Telesforo, C. L., Caltagirone, S. S., Panaccione, I., et al. (2012) · CNS Drugs · doi:10.2165/11634390-000000000-00000 · Cited by 273
The role of glutamate signaling in the pathogenesis and treatment of obsessive-compulsive disorder
Wu, K., Hanna, G. L., Rosenberg, D. R., & Arnold, P. D. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.10.007 · Cited by 264
A Single-Blinded Case-Control Study of Memantine in Severe Obsessive-Compulsive Disorder
Stewart, S. E., Jenike, E. A., Hezel, D. M., Stack, D. E., Dodman, N. H., Shuster, L., & Jenike, M. A. (2010) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3181c856de · Cited by 158
Self-citationGhaleiha, A., Entezari, N., Modabbernia, A., Najand, B., Askari, N., Tabrizi, M., Ashrafi, M., Hajiaghaee, R., & Akhondzadeh, S. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2012.09.015 · Cited by 152
Haghighi, M., Jahangard, L., Mohammad-Beigi, H., Bajoghli, H., Hafezian, H., Rahimi, A., Afshar, H., Holsboer‐Trachsler, E., & Brand, S. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3067-z · Cited by 121
The neurobiological link between OCD and ADHD
Brem, S., Grünblatt, E., Drechsler, R., Riederer, P., & Walitza, S. (2014) · ADHD Attention Deficit and Hyperactivity Disorders · doi:10.1007/s12402-014-0146-x · Cited by 109
Murphy, D. L., Moya, P. R., Fox, M. A., Rubenstein, L. M., Wendland, J. R., & Timpano, K. R. (2013) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2012.0435 · Cited by 106
Assessment and Management of Treatment-Refractory Obsessive-Compulsive Disorder in Children
Bloch, M. H., & Storch, E. A. (2015) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2015.01.011 · Cited by 104
Glutamate-Modulating Drugs as a Potential Therapeutic Strategy in Obsessive-Compulsive Disorder
Marinova, Z., Chuang, D.-M., & Fineberg, N. (2017) · Current Neuropharmacology · doi:10.2174/1570159x15666170320104237 · Cited by 83
A review of obsessive-compulsive disorder in children and adolescents
Boileau, B. (2011) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2011.13.4/bboileau · Cited by 102
Haghighi, M., Shayganfard, M., Jahangard, L., Ahmadpanah, M., Bajoghli, H., Pirdehghan, A., Holsboer‐Trachsler, E., & Brand, S. (2015) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2015.06.020 · Cited by 83
Glutamatergic agents for OCD and related disorders
Pittenger, C. (2015) · Current Treatment Options in Psychiatry · doi:10.1007/s40501-015-0051-8 · Cited by 62
Emamzadehfard, S., Kamaloo, A., Paydary, K., Ahmadipour, A., Zeinoddini, A., Ghaleiha, A., Mohammadinejad, P., Zeinoddini, A., & Akhondzadeh, S. (2016) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12394 · Cited by 55
Pharmacotherapeutic Strategies and New Targets in OCD
Pittenger, C. (2021) · Current topics in behavioral neurosciences · doi:10.1007/7854_2020_204 · Cited by 59
Heidari, M., Zarei, M., Hosseini, S. M. R., Taghvaei, R., Maleki, H., Tabrizi, M., Fallah, J., & Akhondzadeh, S. (2014) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000043 · Cited by 48
Investigational and Experimental Drugs to Treat Obsessive-Compulsive Disorder
Grassi, G., Cecchelli, C., Vignozzi, L., & Pacini, S. (2021) · Journal of Experimental Pharmacology · doi:10.2147/jep.s255375 · Cited by 44
Memantine: a review of possible uses in child and adolescent psychiatry.
Hosenbocus, S., & Chahal, R. (2013) · Europe PMC (PubMed Central) · Cited by 64
Advances in pharmacotherapy for pediatric anxiety disorders
Rynn, M., Puliafico, A., Heleniak, C., Rikhi, P., Ghalib, K., & Vidair, H. (2011) · Depression and Anxiety · doi:10.1002/da.20769 · Cited by 44
Grados, M. A., Atkins, E., Kovacikova, G. I., & McVicar, E. L. (2015) · Psychology Research and Behavior Management · doi:10.2147/prbm.s58601 · Cited by 45
The Use of Memantine in Neuropsychiatric Disorders: An Overview
Lu, S., & Nasrallah, H. A. (2018) · Annals of Clinical Psychiatry · doi:10.1177/104012371803000307 · Cited by 45
Muñoz, M., Ausín, B., Santos‐Olmo, A. B., Härter, M. C., Volkert, J., Schulz, H., Sehner, S., Dehoust, M. C., Suling, A. I., Wegscheider, K., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0196574 · Cited by 39
Role of Glutamatergic System in Obsessive-Compulsive Disorder with Possible Therapeutic Implications
Vlček, P., Polák, J., Brunovský, M., & Horáček, J. (2017) · Pharmacopsychiatry · doi:10.1055/s-0043-118665 · Cited by 33
The Nature, Assessment, and Treatment of Obsessive–Compulsive Disorder
McGuire, J. F., Lewin, A. B., Horng, B., Murphy, T. K., & Storch, E. A. (2012) · Postgraduate Medicine · doi:10.3810/pgm.2012.01.2528 · Cited by 28
Current and up-and-coming pharmacotherapy for obsessive-compulsive disorder in adults
Grassi, G., & Pallanti, S. (2018) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2018.1528230 · Cited by 29
Emerging drugs to treat obsessive–compulsive disorder
Pallanti, S., Grassi, G., & Cantisani, A. (2013) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.2014.875157 · Cited by 26
Treating anxiety disorders in children and adolescents with epilepsy: What do we know?
Jones, J. E. (2014) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2014.06.021 · Cited by 23
Assessment and Medication Management of Paediatric Obsessive-Compulsive Disorder
Stewart, S. E., Hezel, D. M., & Stachon, A. C. (2012) · Drugs · doi:10.2165/11632860-000000000-00000 · Cited by 22
Self-citationThe Glutamate and the Immune Systems: New Targets for the Pharmacological Treatment of OCD
Marazziti, D., Albert, U., Mucci, F., & Piccinni, A. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867324666171108152035 · Cited by 20
Management of obsessive-compulsive disorder comorbid with bipolar disorder
Kazhungil, F., & Mohandas, E. (2016) · Indian Journal of Psychiatry · doi:10.4103/0019-5545.192001 · Cited by 19
Treatment of pediatric anxiety disorders
Rapp, A. M., Dodds, A., Walkup, J. T., & Rynn, M. A. (2013) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12318 · Cited by 19
Psychotherapeutische und medikamentöse Behandlung der kindlichen Zwangsstörung
Vloet, T. D., Simons, M., & Herpertz‐Dahlmann, B. (2011) · Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie · doi:10.1024/1422-4917/a000147 · Cited by 15
Murphy, T. K., Frazier, S., & Kim, S. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-252-6_10 · Cited by 12
Evidence-Based Pharmacotherapy for Pediatric Obsessive-Compulsive Disorder and Chronic Tic Disorders
Nadai, A. S. D., Storch, E. A., Mcguire, J. F., Lewin, A. B., & Murphy, T. K. (2011) · Journal of Central Nervous System Disease · doi:10.4137/jcnsd.s6616 · Cited by 10
Pekrul, S. R., & Fitzgerald, K. D. (2015) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2015.0073 · Cited by 9
Tsai, G. E. (2016) · Advances in pharmacology · doi:10.1016/bs.apha.2016.03.003 · Cited by 11
Niemeyer, L., Mechler, K., Dittmann, R., Banaschewski, T., Buitelaar, J. K., Durston, S., & Häge, A. (2022) · Contemporary Clinical Trials Communications · doi:10.1016/j.conctc.2022.100982 · Cited by 9
Yazıcı, K., & Perçinel, I. (2014) · Journal of child and adolescent psychopharmacology · doi:10.1089/cap.2014.0053 · Cited by 9
Stewart, S. E. (2016) · Springer eBooks · doi:10.1007/978-1-59745-495-7_2 · Cited by 11
Self-citationWu, P.-L., Lane, H., Tang, H., & Tsai, G. E. (2012) · Biomedicine · doi:10.1016/j.biomed.2012.04.003 · Cited by 4
Arnold, P. D., & Kronenberg, S. (2017) · Wiley eBooks · doi:10.1002/9781118890233.ch60 · Cited by 4
Advances in Pharmacotherapy for Pediatric Anxiety Disorders
Rynn, M. A., Puliafico, A. C., Heleniak, C. M., Rikhi, P., Ghalib, K., & Vidair, H. B. (2011) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/foc.9.3.foc299 · Cited by 2
Vloet, T. D., Herpertz‐Dahlmann, B., & Simons, M. (2016) · Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie · doi:10.1024/1422-4917/a000445 · Cited by 5
Cognitive-Behavioral Therapy of Obsessive-Compulsive Disorder in Children and Adolescents
Çimen, İ. D. (2018) · InTech eBooks · doi:10.5772/intechopen.70612 · Cited by 2
Approaches to Treatment Resistance
Pallanti, S., Grassi, G., & Cantisani, A. (2012) · Wiley eBooks · doi:10.1002/9781119941125.ch5 · Cited by 2
Psychopharmacology for Pediatric OCD and Related Disorders
Greenberg, E., Johnson, G., & GELLER, D. A. (2024) · Springer eBooks · doi:10.1007/978-3-031-57472-6_10 · Cited by 1
The Use of Glutamate Modulating Drugs in Obsessive Compulsive Disorder
MacMaster, F. P., & Rosenberg, D. R. (2010) · Child and Adolescent Psychopharmacology News · doi:10.1521/capn.2010.15.6.1 · Cited by 2
Trastorno obsesivo-compulsivo en niños y adolescentes: una revisión del tratamiento
Flores, R. E. U., Cruz, L. P., & Vera, T. D. R. S. (2011) · Salud Mental
Managing a Child With OCD Who Is Treatment Refractory
Bloch, M. H. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811427-8.00017-4
Rosenberg, D. R., Easter, P. C., & Michalopoulou, G. (2012) · Wiley eBooks · doi:10.1002/9781119941125.ch10
Nutritional Deficiencies in Obsessive-Compulsive Disorder and Possible Treatment Interventions
Sethi, P., Kumar, S., Prajapati, A., Irfanullah, Z., Jatchavala, C., Vadivel, R., & Hayek, S. E. (2022) · Nutritional neurosciences · doi:10.1007/978-981-19-5021-6_9
Chapter 52. Treatment of Obsessive-Compulsive Disorder
Kayser, R. R., & Simpson, H. B. (2024) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615375523.as52 · Cited by 1
Innovative treatment approaches for paediatric obsessive-compulsive disorder
Marazziti, D., Gurrieri, R., Gambini, M., Russomanno, G., Palagini, L., & Mucci, F. (2025) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2025.2591073
Pharmacological treatment of obsessive-compulsive disorder in children and adolescents: An overview
Rajalakshmi, A. K., Pawar, A. K. S., & Baweja, R. (2026) · World Journal of Clinical Pediatrics · doi:10.5409/wjcp.v15.i1.114315
Metadata
- Authors
- HEZEL, D. M., BEATTIE, K., & STEWART, S. E.
- Affiliations
- Boston, Mass.
- Venue
- American Journal of Psychiatry
- Published
- 2009-02
- Volume
- 166
- Issue
- 2
- Pages
- 237-237
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W2168172940
- Cited by
- 55
- References
- 7
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 2 · 2022: 2 · 2021: 2 · 2018: 6 · 2017: 3 · 2016: 5 · 2015: 5 · 2014: 4 · 2013: 5 · 2012: 8
- FWCI
- 6.37
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Obsessive-Compulsive Spectrum Disorders
- Social Sciences › Psychology › Clinical Psychology › Psychoanalysis and Psychopathology Research
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Keywords
- memantine, pediatric obsessive-compulsive disorder, pharmacotherapy
- MeSH terms
- Adolescent, Combined Modality Therapy, Drug Therapy, Combination, Female, Follow-Up Studies, Humans, Memantine, Obsessive-Compulsive Disorder, Citalopram, Cognitive Behavioral Therapy, Dopamine Agonists
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.